Huntington's Disease News and Research

Latest Huntington's Disease News and Research

Latrepiridine reduces level of at least two neurodegeneration-related proteins in mice

Latrepiridine reduces level of at least two neurodegeneration-related proteins in mice

Latrepirdine demonstrates new potential against neurodegenerative conditions

Latrepirdine demonstrates new potential against neurodegenerative conditions

Latrepirdine appears effective in treating Alzheimer's disease in animals

Latrepirdine appears effective in treating Alzheimer's disease in animals

Advanced understanding of neurodegenerative diseases achieved by Trophos

Advanced understanding of neurodegenerative diseases achieved by Trophos

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Protein associated with Huntington’s and other neurodegenerative diseases has several brain-specific forms

Protein associated with Huntington’s and other neurodegenerative diseases has several brain-specific forms

GUMC, MedStar GUH launch Huntington Disease Care, Education and Research Center

GUMC, MedStar GUH launch Huntington Disease Care, Education and Research Center

New AAN guideline recommends several treatments for people with Huntington's chorea

New AAN guideline recommends several treatments for people with Huntington's chorea

Statistical method uses evolutionary information to enhance identification of disease-associated alleles

Statistical method uses evolutionary information to enhance identification of disease-associated alleles

Mitochondrial gene regulators involved in Huntington’s disease pathology

Mitochondrial gene regulators involved in Huntington’s disease pathology

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Five recent Science and Nature papers shed light on elusive 'GPCRs'

Five recent Science and Nature papers shed light on elusive 'GPCRs'

New paper documents discovery of novel lipids, including MC3

New paper documents discovery of novel lipids, including MC3

PGC-1alpha and TFEB provide two new therapeutic targets for Huntington's disease

PGC-1alpha and TFEB provide two new therapeutic targets for Huntington's disease

Oligodendroglia cells: An interview with Jeffrey Rothstein

Oligodendroglia cells: An interview with Jeffrey Rothstein

Toxins and cell death: Interview with Professor Denise Montell

Toxins and cell death: Interview with Professor Denise Montell

Study shows cells from different Parkinson’s patients have unique drug responses

Study shows cells from different Parkinson’s patients have unique drug responses

Potential link between mutant huntingtin, cell loss and cell death in Huntington's disease

Potential link between mutant huntingtin, cell loss and cell death in Huntington's disease

Scientists use patient cells to generate human model of Huntington's

Scientists use patient cells to generate human model of Huntington's

New laboratory model for Huntington's disease

New laboratory model for Huntington's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.